No Data
No Data
No Data
No Data
No Data
Sensus Healthcare Issues Reminder That Its First Quarter 2024 Financial Results and Business Update Conference Call Will Be Held on Thursday, May 9, 2024
BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
GlobeNewswireApr 25 20:00
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
GlobeNewswireApr 19 04:05
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare's Growth and Operations
TipRanksMar 17 14:01
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.
GlobeNewswireMar 15 04:05
Sensus Healthcare Launches "Fair Deal Agreement" for Its SRT-100 Vision at the American Academy of Dermatology Annual Meeting
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces the successful launch of its new "Fair Deal Agreement" for the SRT-100 Vision (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego.
GlobeNewswireMar 13 20:00
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for
GlobeNewswireMar 8 05:35
No Data
No Data